Table 1. Intrahepatic disposition of Dox formulations (mean ± SD; n = 4).
Formulations | Hepatocytes(H) (μg) | NPC(μg) | H:NPC ratio | Fold enhancement in hepatocyte accumulationReference: Dox solution |
---|---|---|---|---|
1 h | ||||
Pul-AGn NPs | 13.99 ± 0.24 | 1.78 ± 0.12 | 88.7:11.3 | 134.51 |
AGn NPs | 7.08 ± 0.49 | 1.02 ± 0.10 | 87.4:12.6 | 68.07 |
Pul NPs | 7.95 ± 0.16 | 1.16 ± 0.06 | 87.3:12.7 | 76.44 |
NPs | 1.78 ± 0.17 | 0.814 ± 0.12 | 68.6:31.4 | 17.11 |
Dox solution | 0.10 ± 0.02 | 0.154 ± 0.04 | 40.3:59.7 | Reference |
24 h | ||||
Pul-AGn NPs | 2.38 ± 0.13 | 0.38 ± 0.06 | 86.2:13.8 | |
AGn NPs | 1.11 ± 0.10 | 0.18 ± 0.03 | 86:13.9 | |
Pul NPs | 1.71 ± 0.07 | 0.28 ± 0.03 | 85.9:14 | |
NPs | 1.09 ± 0.10 | 0.45 ± 0.08 | 70.8:29.2 | |
Dox solution | Not detected | Not detected | Reference |